US Drug Recall Register

Is Pine recalled?

Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class III · Low risk Terminated

Isradapine Capsules USP 2.5 mg

Reason Failed Impurities/Degradation Specifications

Elite Laboratories Inc. NDC 42806-263-01 D-0107-2018
Class II · Moderate risk Terminated

Clozapine Tablets USP

Reason Failed Tablet/Capsule Specifications; potential presence of broken tablets.

Teva Pharmaceuticals USA NDC 00093-7772-05 D-0096-2018
Class III · Low risk Terminated

Carbamazepine Oral Suspension USP

Reason Subpotent Drug: low out of specification results.

Precision Dose Inc. NDC 68094-301-59 D-0057-2018
Class II · Moderate risk Terminated

Levophed

Reason Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

Pfizer Inc. NDC 0409-3375-04 D-1168-2017
Class II · Moderate risk Terminated

Norepinephrine 8 mg in dextrose 5% 250 mL

Reason Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0142-2018
Class II · Moderate risk Terminated

Carbamazepine Oral Suspension

Reason Labeling Error: Label mix-up. Products' unit dose cups are correctly labeled, but the product carton lists incorrect volume and NDC.

Precision Dose Inc. NDC 68094-301-59 D-1037-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-464-69 D-0941-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-463-69 D-0940-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-462-69 D-0939-2017
Class II · Moderate risk Terminated

Levophed norepinephrine bitartrate

Reason GMP Deviation; A foreign stopper was observed during packaging of a lot of product.

Hospira Inc., A Pfizer Company NDC 0409-3375-04 D-0898-2017
Class II · Moderate risk Terminated

Saphris 10 mg

Reason Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets

Forest Laboratories, LLC NDC 0456-2410-60 D-0880-2017
Class III · Low risk Terminated

Amlodipine Besylate Tablet

Reason PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Ascend Laboratories LLC NDC 67877-199-10 D-1134-2017